The off-label use of targeted therapies in sarcomas: the OUTC’S program

BACKGROUND: Few targeted therapies (TTs) are registered for sarcoma treatment despite numerous phase II studies and yet there are potential treatment options for patients after standard treatment escape. The French Sarcoma Group - Bone Tumor Study Group (GSF-GETO) created a national registry to eval...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:BMC Cancer
मुख्य लेखकों: Eberst, Lauriane, Cropet, Claire, Le Cesne, Axel, Pautier, Patricia, Penel, Nicolas, Adenis, Antoine, Chevreau, Christine, Bay, Jacques-Olivier, Collard, Olivier, Cupissol, Didier, Duffaud, Florence, Gentet, Jean-Claude, Piperno-Neumann, Sophie, Marec-Berard, Perrine, Bompas, Emmanuelle, Thyss, Antoine, Chaigneau, Loic, Cassier, Philippe, Bertucci, François, Blay, Jean-Yves, Ray-Coquard, Isabelle
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2014
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289372/
https://ncbi.nlm.nih.gov/pubmed/25420707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-870
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन